eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
19 September 2008 - 4:44AM
PR Newswire (US)
PHILADELPHIA, Sept. 18 /PRNewswire-FirstCall/ --
eResearchTechnology, Inc. (eRT), (NASDAQ:ERES), a leading provider
of centralized ECG and eClinical technology, ePRO and other
services to the pharmaceutical, biotechnology, medical device and
related industries, announced today that Dr. Michael J. McKelvey,
the Company's President and Chief Executive Officer, and Keith
Schneck, the Company's Chief Financial Officer, are scheduled to
present at the UBS Global Life Sciences Conference at 3:30 p.m. EDT
on September 23rd, 2008 at the Grand Hyatt Park Avenue Hotel in New
York, New York. Interested parties may access the presentation by
visiting the Company's corporate website at http://www.ert.com/ or
http://www.ibb.ubs.com/. The webcast will be available via replay
for 90 days. Based in Philadelphia, PA, eResearchTechnology, Inc.
(http://www.ert.com/) is a provider of technology and services to
the pharmaceutical, biotechnology and medical device industries on
a global basis. The company is a market leader in providing
centralized core-diagnostic electrocardiographic (ECG) technology
and services to evaluate cardiac safety in clinical development.
The company is also a leader in providing technology and services
to streamline the clinical trials process by enabling its customers
to automate the collection, analysis, and distribution of clinical
data in all phases of clinical development. Statements included in
this release may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements, including but not limited to 2008 financial
guidance, involve a number of risks and uncertainties such as the
company's ability to obtain new contracts and accurately estimate
net revenues due to uncertain regulatory guidance, variability in
size, scope and duration of projects, and internal issues at the
sponsoring client, integration of acquisitions, competitive
factors, technological development, and market demand. As a result,
actual results may differ materially from any financial outlooks
stated herein. Further information on potential factors that could
affect the company's financial results can be found in the
company's Reports on Form 10-K and 10-Q filed with the Securities
and Exchange Commission. The company undertakes no obligation to
publicly update any forward-looking statement, whether as a result
of new information, future events or otherwise. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Keith Schneck of
eResearchTechnology, Inc., +1-215-282-5566 Web site:
http://www.ert.com/ http://www.ibb.ubs.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Technology Inc. (MM) News Articles